Maximizing the clinical outcome with mTOR inhibitors in the renal transplant recipient: defining the role of calcineurin inhibitors
Author:
Publisher
Frontiers Media SA
Subject
Transplantation
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1432-2277.2004.tb00444.x/fullpdf
Reference42 articles.
1. MULTICENTER TRIAL EXPLORING CALCINEURIN INHIBITORS AVOIDANCE IN RENAL TRANSPLANTATION
2. Cyclosporine withdrawal from a mycophenolate mofetil???containing immunosuppressive regimen in stable kidney transplant recipients: a randomized, controlled study1,2
3. LONG-TERM RENAL ALLOGRAFT SURVIVAL
4. Cyclosporin withdrawal with concomitant conversion from azathioprine to mycophenolate mofetil in renal transplant recipients with chronic allograft nephropathy: a 2-year follow-up
5. A prospective, randomized clinical trial of cyclosporine reduction in stable patients greater than 12 months after renal transplantation
Cited by 32 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Effect of Sirolimus vs. Everolimus on CMV-Infections after Kidney Transplantation—A Network Meta-Analysis;Journal of Clinical Medicine;2022-07-20
2. Infections after kidney transplantation: A comparison of mTOR‐Is and CNIs as basic immunosuppressants. A systematic review and meta‐analysis;Transplant Infectious Disease;2020-03-06
3. Case Report: Renal Cell Carcinoma of First Kidney Allograft in Transplanted Recipient for Second Time;Urology & Nephrology Open Access Journal;2016-12-30
4. Design and rationale of the ATHENA study – A 12-month, multicentre, prospective study evaluating the outcomes of a de novo everolimus-based regimen in combination with reduced cyclosporine or tacrolimus versus a standard regimen in kidney transplant patients: study protocol for a randomised controlled trial;Trials;2016-02-17
5. Effects of Storage Temperature and Time on Stability of Serum Tacrolimus and Cyclosporine A Levels in Whole Blood by LC-MS/MS;International Journal of Analytical Chemistry;2015
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3